Jim Cramer on Insulet Corporation: “It's Still Too Expensive Because of the GLP-1 Threat” [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
stocks . Toward the end of the lightning round, a caller sought Cramer's opinion of the stock, and he said: Insulet is the stock in the healthcare group. It is the biggest decline of any stock in the healthcare group, and I looked at it today to see if I could recommend it. It's still too expensive because of the GLP-1 threat, existential. Photo by Adam Nowakowski on Unsplash Insulet Corporation (NASDAQ:PODD) develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers the Omnipod platform, including the Omnipod 5 automated insulin delivery system and Omnipod DASH, along with the broader Omnipod Insulin Management System. Parnassus Investments stated the following regarding Insulet Corporation (NASDAQ:PODD) in its third quarter 2025 investor letter Insulet Corporation (NASDAQ:PODD) is the sole manufacturer of a tubeless insulin pump to treat diabetes. The company has durable competitive advantages from its intellectual proper
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Insulet (PODD) Ends April With Strong Analyst Sentiment Amid Strong Earnings Expectations [Yahoo! Finance]Yahoo! Finance
- Insulet to Participate in BofA Securities 2026 Health Care ConferenceBusiness Wire
- How The Insulet (PODD) Narrative Is Shifting After Omnipod 5 Correction And Repriced Expectations [Yahoo! Finance]Yahoo! Finance
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODDACCESS Newswire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODDACCESS Newswire
PODD
Earnings
- 2/18/26 - Beat
PODD
Sec Filings
- 4/29/26 - Form 8-K
- 4/6/26 - Form DEFA14A
- 4/6/26 - Form DEF
- PODD's page on the SEC website